Treatment of psychosis in children and adolescents

Psychiatric Annals

Volumn 33, Issue 4, 2003, Pages 257-264

  Birmaher, Boris ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ACUTE KIDNEY TUBULE NECROSIS; AGGRESSION; AGITATION; AKATHISIA; ANOREXIA; ANXIETY DISORDER; APPETITE DISORDER; AUTISM; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLOOD TOXICITY; BRADYKINESIA; CHILD PSYCHIATRY; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DIZZINESS; DRUG METABOLISM; DYSPHAGIA; DYSTONIA; GALACTORRHEA; GASTROINTESTINAL DISEASE; GYNECOMASTIA; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPOMANIA; HYPOTENSION; ILLUSION; IRRITABILITY; LIVER DISEASE; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIA; MENSTRUATION DISORDER; MENTAL CONCENTRATION; MOTIVATION; MUSCLE RIGIDITY; MYOGLOBINURIA; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; NEUTROPENIA; PATIENT EDUCATION; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; QT PROLONGATION; RASH; REVIEW; RIGIDITY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SKIN DISEASE; SLEEP PATTERN; STOMATITIS; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SWEATING; SYMPTOM; SYNCOPE; TACHYCARDIA; THORAX PAIN; TIC; TORSADE DES POINTES; TREMOR; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 1942467433     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030401-06     Document Type: Review

References (40)

1. Volkmar FR. Childhood and adolescent psychosis: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1996;35:843-851.
2. Caplan R, Tanguay PE. Development of psychotic thinking in children. In: Lewis M, ed. Child and Adolescent Psychiatry, A Comprehensive Textbook. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:359-366.
3. Ulloa RE, Birmaher B, Axelson D, et al. Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates. J Am Acad Child Adolesc Psychiatry. 2000;39:337-345.
4. Fennig S, Susser ES, Pilowsky DJ, Fennig S, Bromet EJ. Childhood hallucinations preceding the first psychotic episode. J Nerv Ment Dis. 1997;185:115-117.
5. Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41:934-941.
6. Lohr D, Birmaher B. Psychotic disorders. Child Adolesc Psychiatr Clin N Am. 1995;4:237-254.
7. Werry JS. Child and adolescent (early onset) schizophrenia: a review in the light of DSM-III-R. J Autism Dev Disord. 1992;22:610-624.
8. Campbell M, Rapoport JL, Simpson GM. Antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:537-545.
9. Bryden KE, Carrey NJ, Kutcher SP. Update and recommendations for the use of antipsychotics in early-onset psychoses. J Child Adolesc Psychopharmacol. 2001;11:113-130.
10. Gracious BL, Findling RL. Antipsychotic medications for children and adolescents. Pediatr Ann. 2001;30:138-145.
11. Remschmidt H, Hennighausen K, Clement HW, Heiser P, Schulz E. Atypical neuroleptics in child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2000;9(suppl 11):I9-19.
12. Birmaher B, Ryan ND, Brent DA, Williamson DE, Kaufman J. Childhood and adolescent depression: a review of the past ten years. Part II. J Am Acad Child Adolesc Psychiatry. 1996;35:1575-1583.
13. Alaghband-Rad J, McKenna K, Gordon CT, et al. Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry. 1995;34:1273-1283.
14. McGlashan TH. Early detection and intervention with schizophrenia: rationale and research. Br J Psychiatry Suppl. 1998;172:3-6.
15. McGorry P. Preventive strategies in early psychosis: verging on reality. Br J Psychiatry Suppl. 1998;172:1-2.
16. Hughes CW, Rintelmann J, Emslie GJ, Lopez M, MacCabe N. A revised anchored version of the BPRS-C for childhood psychiatric disorders. J Child Adolesc Psychopharmacol. 2001;11:77-93.
17. Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull. 1985;21:714-1124.
18. Kumra S. The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me." Child Adolesc Psychiatr Clin N Am. 2000;9:183-199.
19. Tauscher J, Kapur S. Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies. CNS Drugs. 2001;15:671-678.
20. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and metaanalysis of randomized trials. Am J Psychiatry. 2001;158:518-526.
21. Kumra S, Frazier JA, Jacobsen LK, et al. Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry. 1996;53:1090-1097.
22. Birmaher B, Baker R, Kapur S, Quintana H, Ganguli R. Clozapine for the treatment of adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 1992;31:160-164.
23. Van Bellinghen M, De Troch C. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2001;11:5-13.
24. Mehler C, Wewetzer C, Schulze U, Warnke A, Theisen F, Dittmann RW. Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases. Eur Child Adolesc Psychiatry. 2001;10:151-157.
25. Stigler KA, Potenza MN, McDougle CJ. Tolerability profile of atypical antipsychotics in children and adolescents. Paediatr Drugs. 2001;3:927-942.
26. Physicians' Desk Reference 56th Edition. Montvale, NJ: Medical Economics Co.; 2002.
27. Meyer J. Novel antipsychotics and severe hyperlipidemia. J Clin Psychopharmacol. 2001;21:369-374.
28. Wetterling T. Bodyweight gain with atypical antipsychotics. A comparative review. Drug Safe. 2001;24:59-73.
29. Wudarsky M, Nicolson R, Hamburger SD, et al. Elevated prolactin in pediatric patients on typical and atypical antipsychotics. J Child Adolesc Psychopharmacol. 1999;9:239-245.
30. Grothe DR, Calis KA, Jacobsen L, et al. Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. J Clin Psychopharmacol. 2000;20:220-225.
31. Emslie GJ, Rush AJ, Weinberg AW, et al. A double-blind, randomized placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031-1037.
32. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry.
33. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40:762-772.
34. Practice for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry. 2000;157(suppl 4):1-45.
35. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713-720.
36. Kafantaris V, Coletti DJ, Dicker R, Padula G, Pollack S. Are childhood psychiatric histories of bipolar adolescents associated with family history, psychosis, and response to lithium treatment? J Affect Disord. 1998;51:153-164.
37. Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41:1216-1223.
38. Gonzalez-Pinto A, Lalaguna B, Mosquera F, et al. Use of olanzepine in dysphoric mania. J Affect Disord. 2001;66:247-253.
39. Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001;11:239-250.
40. Brent DA, Poling K, McKain B, Baugher M. A psychoeducational program for families of affectively ill children and adolescents. J Am Acad Child Adolesc Psychiatry. 1993;32: 770-774.